| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.676 | 28.968 | 104.482 | 216.463 | 107.675 | 90.310 |
| Total Income - EUR | - | - | - | - | 1.676 | 29.045 | 104.482 | 216.923 | 107.730 | 118.389 |
| Total Expenses - EUR | - | - | - | - | 1.296 | 16.568 | 34.821 | 53.951 | 104.496 | 75.549 |
| Gross Profit/Loss - EUR | - | - | - | - | 380 | 12.477 | 69.661 | 162.972 | 3.233 | 42.840 |
| Net Profit/Loss - EUR | - | - | - | - | 329 | 11.866 | 66.526 | 158.298 | 2.318 | 39.359 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Implaorto Terapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 20.670 | 17.924 | 56.361 | 41.956 | 11.652 |
| Current Assets | - | - | - | - | 3.006 | 155 | 65.679 | 105.794 | 24.810 | 69.733 |
| Inventories | - | - | - | - | 2.827 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 440 | 94.196 | 1.846 | 0 |
| Cash | - | - | - | - | 179 | 155 | 65.239 | 11.598 | 22.963 | 69.733 |
| Shareholders Funds | - | - | - | - | 371 | 12.231 | 78.486 | 158.347 | 62.770 | 39.408 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.634 | 8.607 | 5.205 | 4.435 | 4.782 | 41.989 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 228 | 188 | 148 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Implaorto Terapy S.r.l.